Search

Your search keyword '"Gouraud, Wilfried"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Gouraud, Wilfried" Remove constraint Author: "Gouraud, Wilfried"
179 results on '"Gouraud, Wilfried"'

Search Results

7. Supplementary Table 3 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma

8. Supplementary Table 4 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma

9. Supplementary Figures from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma

10. Supplementary Table 2 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma

11. Supplementary Table 1 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma

12. Abstract P5-02-37: Multi-omics approach to identify markers of resistance to endocrine therapy + CDK4/6 inhibitors in first line HR+/HER2- metastatic breast cancer (MBC) patients

19. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches

22. Additional file 18: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

23. Additional file 29: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

24. Additional file 5: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

25. Additional file 3: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

26. Additional file 4: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

27. Additional file 9: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

28. Additional file 6: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

29. Additional file 7: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

30. Additional file 8: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

31. RUBY: A phase II study testing rucaparib in germline (g) BRCA wild-type patients presenting metastatic breast cancer (mBC) with homologous recombination deficiency (HRD).

33. c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1

34. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients

35. Logic programming reveals alteration of key transcription factors in multiple myeloma

36. An open-label, phase II study of rucaparib, a PARP inhibitor, in HER2- metastatic breast cancer patients with high genomic loss of heterozygosity: RUBY.

37. Additional file 2: of Gene-expression signature functional annotation of breast cancer tumours in function of age

39. Additional file 6: of Gene-expression signature functional annotation of breast cancer tumours in function of age

45. Additional file 3: of Gene-expression signature functional annotation of breast cancer tumours in function of age

46. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma

48. Abstract P2-04-07: Gene-expression molecular subtyping of immunohistochemistry-typed triple-negative breast cancer tumours

49. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response

50. A Genome Wide Association Study Reveals Genetic Predisposition for Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma By Variation in the PREP1-Cbs Locus

Catalog

Books, media, physical & digital resources